All News

Dr. Eder at RNL

Sex Disparities in PsA/SpA

Kathryn H. Dao, M.D.

Dr. Eder delivered an illuminating talk at RheumNow Live 2024 on sex differences in psoriatic arthritis; the disease may manifest differently in men and women, and therapeutic responses may differ between the sexes.

Read Article
RheumNow Podcast square

VITAL Info on Autoimmune Disease (2.9.2024)

Jack Cush, MD

Dr. Jack Cush reviews the journal reports from the past week on RheumNow.com. Highlights are summarized by three songs: "Stairway to Heaven", "You're No Good", and "How Long (has this been going on)".

Read Article
PSA%20026.jpg

Racial and Ethnic Determinants of Psoriatic Arthritis

Jack Cush, MD

A study from a large metropolitan registry of psoriatic arthritis (PsA) patients showed several racial and/or ethnic groups are underrepresented and demonstrate differences in disease activity.

Read Article
labs2.jpg

Pre-Treatment Testing with Biologics Falls Short

Jack Cush, MD

US commercial insurance claim analysis of laboratory screening and monitoring practices in chronic inflammatory skin disease (CISD) patients shows that < 60% received the recommended pretreatment testing when starting systemic immunomodulatory treatment.

Read Article
Back Pain

Outcomes of Acute, Subacute and Persistent Low Back Pain

EurekAlert!

Low back pain is a major cause of disability around the globe, with more than 570 million people affected. In the United States alone, health care spending on low back pain was $134.5 billion between 1996 and 2016, and costs are increasing.

Read Article
Korean Database study of 1796 #AS pf (vs 7184 controls 1:4 ratio); 9.3% develeoped cancer; AS pts have no overall increase in cancer risk (aHR 1.1); AS pts had higher risk ofupper GI cancer (HR: 1.51) & hematologic CA (aHR: 2.36). Is there an NSAID effect? https://t.co/6W68upVQrn https://t.co/RWlhLFV9EJ

Links:

Dr. John Cush RheumNow ( View Tweet)
16% of patients with nr-axSpA progressed to r-axSpA within 5 years. Male sex, fulfillment of the imaging arm of the ASAS criteria, and good response to nonsteroidal anti-inflammatory drugs were predictors of radiographic progression https://t.co/2qCynSGQjv https://t.co/eogKGacpqH

Links:

Dr. John Cush RheumNow ( View Tweet)
Rheumatologists and the Early Diagnosis of Spondyloarthritis SPACE study of adults referred to rheumatology with less than 2 years of chronic back pain (CBP), shows that only one-third can be reliably diagnosed with axial spondyloarthritis (axSpA). https://t.co/nUappTl0wG. https://t.co/oouir55CO6

Links:

Dr. John Cush RheumNow ( View Tweet)
#RNL2024 @RheumNow SPA spectrum Q and A 🔥 - @lihi_eder 👏advocating for #POCUS #mskus and enthesitis - we agree @CrusSurc - confirming the concept of #pocus as an extension of the clinical exam and to be kept in the hands of the clinician - doesn't seem an area yet for AI 🤖

CRUS-SURC CrusSurc ( View Tweet)

Dr. @lihi_eder approaches enthesitis both clinically and with imaging *highly recommended. NSAIDs and local steroids may be useful with caution. Advanced tx strongly recommended if initial tx fails/other domains involved. #RNL2024 @RheumNow https://t.co/SKrWmp115M

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Advanced therapies in enthesitis. Don't believe the spin, they all work, no clear evidence that any agent is better than others. @lihi_eder @RheumNow #RNL2024 https://t.co/FwLMUmmClB

Links:

Richard Conway RichardPAConway ( View Tweet)
@JointMD updates us on nomenclature. "AS" is out and "AxSpA" is in. #RNL2024 @RheumNow https://t.co/gdmZeuMNpW

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
#RNL2024 @RheumNow @lihi_eder on enthesitis - ~1/3 PsA, SpA - Enthesitis precedes onset of PsA in PsO, high u/s score ass. w/ RFs (BMI, nail dyst) - Exam: tenderness (non-specific), as swelling uncommon. U/s helpful, but non-specif - Marker of severity, higher risk of damage

Eric Dein ericdeinmd ( View Tweet)

Dr. @lihi_eder recommends enthesial evaluation with POC ultrasound if available in addition to her clinical evaluation. #RNL2024 @RheumNow https://t.co/LQiyFK5VB1

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
AS v nr-AxSpA for TNFi - no diff in response @JointMD @RheumNow #RNL2024 ADA: ASAS20 AS 58%, nr-AxSpA 52%, ASAS40 AS 39%, nr 36% (ATLAS, ABILITY-1) ETN: ASAS 20 59%/52%, ASAS50/40 44%/33% in p3 AS study v EMBARK CZP: RAPID-AxSpA - no diff bw AS & nr-AxSpA response in same trial https://t.co/Rau2CDYbY4

Links:

Eric Dein ericdeinmd ( View Tweet)
#RNL2024 @RheumNow @JointMD on AxSpA SPEED study: roughly 1/2 AS have AxSpA, 1/2 have nr-AxSpA Are they similar: - Yes, but r-axSpA less F and more abnml CRP = Low progression of nr-AxSpA to AS - only 26% progressed in mean 10.6 yrs https://t.co/Vwf5HaMcgu

Links:

Eric Dein ericdeinmd ( View Tweet)
Disease activity indices may perform differently in man and women. @lihi_eder #RNL2024 @RheumNow https://t.co/8G1D0pGKe8

Links:

Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Diagnostic delay in SpA 2.3 years longer delay in diagnosis in women with PsA. @lihi_eder #RNL2024 @RheumNow https://t.co/d9ao8vvpa5

Links:

Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Amazing talk by @lihi_eder on sex differences in PsA. #RNL2024 @RheumNow https://t.co/PW5fYLYmu5

Links:

Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Dr. Lihi Eder discusses the differences between sex and gender. Sex is a biologically-based construct defining differences between male and female Gender has socio-cultural aspects of being a man, woman, or other AND has effect on social norms/expectations BOTH are important to… https://t.co/iceTS0w5LY https://t.co/slSQMwF91J

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×